Louise Gagnon
Top five treatment mainstays: Ulcerated pediatric hemangiomas
Top five treatment mainstays: Ulcerated pediatric hemangiomas
Read and learn the key element to managing ulcerated pediatric hemangiomas.
Oral contraceptives effective for long-term acne treatment
Hormonal therapy is effective in treating acne, but patients will likely have to remain on hormonal therapy long-term to maintain the benefits.
Collaborative care challenges
Clinicians agree that multi-disciplinary teams are the optimal approach to managing advanced melanoma, for they aim for consistent messaging to patients about treatment and require that physicians who are members of the team support their therapeutic choices with evidence. However, obstacles include geographical challenges in community care, treatment sequencing and bias, and physician communication.
5 vital wound care factors
5 vital wound care factors
Factors such as moisture and compression are necessary for wounds to heal and obstacles such as pressure and friction need to be removed.
Advances in burn care for kids
The use of closed dressings in pediatric wound care has shortened hospital stays, decreased dressing changes, and lessened the need for feeding tubes and pain medication.
Epidemiology of BCC
Basal cell carcinoma (BCC) is the most common cancer in the world, with the overall incidence significantly rising across the globe by about 3 to 10% annually.
Hh inhibitors a less invasive tx for BCC
Advances in research have led to the emergence of medical therapies for BCCs; more research is needed to develop systemic therapies to treat SCCs.
Evidence-based guidance for psoriasis treatment
Evidence-based guidance for psoriasis treatment
Newer therapies to treat psoriasis and psoriatic arthritis are more likely to be successful in patients with no prior exposure to biologics. Traditional therapies remain an option but, unlike newer treatments, require monitoring for toxicities.
Rapid responders may offer clues to optimize immune therapy
Some patients respond more rapidly to immune therapies like ipilimumab, and clinicians have observed delayed toxicities with prolonged use of checkpoint inhibitors; effective treatments for subtypes of melanoma, such as uveal melanoma, have not yet emerged.
Scleroderma skin ulcers
Scleroderma skin ulcers are challenging to manage and can be approached with a variety of therapies and treatments.


View Results